Cutaneous leishmaniasis. Treatment with itraconazole.
The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters.
Albanese
G
G
Department of Dermatology, S. Gerardo Hospital, Monza, Italy.
Giorgetti
P
P
Santagostino
L
L
Crippa
D
D
Sala
G
G
D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male
D000981:Antiprotozoal Agents; D017964:Itraconazole; D007654:Ketoconazole